Who founded Vima Therapeutics, Inc.?

Vima Therapeutics, Inc. was founded by Bernard Ravina.

Who are Vima Therapeutics, Inc.'s investors?

Vima Therapeutics, Inc.'s investors include Atlas Venture, Frazier Life Sciences, Access Industries, Access Biotechnology, Canaan Partners.

Vima Therapeutics, Inc.

26 employees on LinkedIn · 5 known investors

Find your way into Vima Therapeutics, Inc.

Each arrow is one introduction. Sign up to fill in the first one.

134 people can intro you to Ariel

Ask Celso Grisi to introduce you to Ariel D. Jasie

You →Celso · together at Fox Horan & Camerini LLP →Ariel

104 people can intro you to Tushar

Ask Jamie Chen to introduce you to Tushar Misra

You →Jamie · together at Wave Life Sciences →Tushar

Your email: who you already know at Vima Therapeutics, Inc., and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vima Therapeutics, Inc. team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.

Biotech Healthtech Medical Devices

Founders & leadership

Bernard RavinaFounder and Chief Executive Officer

Judy DunnPresident of Research & Development

Jessica FeesChief Financial Officer

Ariel D. Jasie Chief Business Officer and General CounselAriel D. Jasie is Chief Business Officer and General Counsel at Vima Therapeutics, a biotech company developing treatments for movement and neurological disorders.

Tushar Misra Chief Technical OfficerTushar Misra is Chief Technical Officer at Vima Therapeutics. He brings over 20 years of pharmaceutical development and manufacturing experience, including roles at Mersana, Wave Life Sciences, Takeda, and Sunovion focused on small-molecule, biologic, and oligonucleotide products across clinical development, scale-up, and commercial operations.

Investors · 5

Atlas Venture✓ confirmed by Vima Therapeutics, Inc.Cambridge · $500K – $1M

How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Frazier Life Sciences✓ confirmed by Vima Therapeutics, Inc.Palo Alto

How we know: the company's own site · Not right? Tell us

Access Industries✓ confirmed by Vima Therapeutics, Inc.New York

How we know: the company's own site · Not right? Tell us

Access Biotechnologylisted by Access BiotechnologyNew York

How we know: Access Biotechnology's portfolio page · Not right? Tell us

Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M

How we know: Canaan Partners's portfolio page · Not right? Tell us

Frequently asked questions

What does Vima Therapeutics, Inc. do?: Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.
Who founded Vima Therapeutics, Inc.?: Vima Therapeutics, Inc. was founded by Bernard Ravina.
Who are Vima Therapeutics, Inc.'s investors?: Vima Therapeutics, Inc.'s investors include Atlas Venture, Frazier Life Sciences, Access Industries, Access Biotechnology, Canaan Partners.